Arijit Roy

Bio: Arijit Roy is an academic researcher from Harvard University. The author has contributed to research in topics: Conditional probability distribution & Chemical space. The author has an hindex of 1, co-authored 1 publications receiving 1 citations.

Using Domain-Knowledge to Assist Lead Discovery in Early-Stage Drug Design

Abstract: We are interested in generating new small molecules which could act as inhibitors of a biological target, when there is limited prior information on target-specific inhibitors. This form of drug-design is assuming increasing importance with the advent of new disease threats for which known chemicals only provide limited information about target inhibition. In this paper, we propose the combined use of deep neural networks and Inductive Logic Programming (ILP) that allows the use of symbolic domain-knowledge (B) to explore the large space of possible molecules. Assuming molecules and their activities to be instances of random variables X and Y, the problem is to draw instances from the conditional distribution of X, given Y,B (DX|Y,B). We decompose this into the constituent parts of obtaining the distributions DX|B and DY|X,B, and describe the design and implementation of models to approximate the distributions. The design consists of generators (to approximate DX|B and DX|Y,B) and a discriminator (to approximate DY|X,B). We investigate our approach using the well-studied problem of inhibitors for the Janus kinase (JAK) class of proteins. We assume first that if no data on inhibitors are available for a target protein (JAK2), but a small numbers of inhibitors are known for homologous proteins (JAK1, JAK3 and TYK2). We show that the inclusion of relational domain-knowledge results in a potentially more effective generator of inhibitors than simple random sampling from the space of molecules or a generator without access to symbolic relations. The results suggest a way of combining symbolic domain-knowledge and deep generative models to constrain the exploration of the chemical space of molecules, when there is limited information on target-inhibitors. We also show how samples from the conditional generator can be used to identify potentially novel target inhibitors.

How to Tell Deep Neural Networks What We Know: A Review of Methods for Inclusion of Domain-Knowledge

Abstract: We present a short survey of ways in which existing scientific knowledge are included when constructing models with neural networks. The inclusion of domain-knowledge is of special interest not just to constructing scientific assistants, but also, many other areas that involve understanding data using human-machine collaboration. In many such instances, machine-based model construction may benefit significantly from being provided with human-knowledge of the domain encoded in a sufficiently precise form. This paper examines the inclusion of domain-knowledge by means of changes to: the input, the loss-function, and the architecture of deep networks. The categorisation is for ease of exposition: in practice we expect a combination of such changes will be employed. In each category, we describe techniques that have been shown to yield significant changes in network performance.